Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Anne Floquet

3PUBLICATIONS

32CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jun 04, 2024

Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.

Gilles Freyer, Anne Floquet, Olivier Tredan

|Mar 05, 2024

Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.

Gilles Freyer, Anne Floquet, Olivier Tredan

|Jun 28, 2023

Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas.

Anne-Sophie Sertier, Anthony Ferrari, Roxane M Pommier

Pageof 1

Frequent Collaborators

2 joint publications

Michele Lamuraglia

2 joint publications

Michel Fabbro

2 joint publications

Frédéric Selle

2 joint publications

Gilles Freyer

1 joint publications

Anthony Ferrari

1 joint publications

Roxane M Pommier

1 joint publications

Isabelle Treilleux

1 joint publications

Sandrine Boyault

1 joint publications

Mojgan Devouassoux-Shisheboran

1 joint publications

Emilie Thomas

Frequent Collaborators

2 joint publications

Michele Lamuraglia

2 joint publications

Michel Fabbro

2 joint publications

Frédéric Selle

2 joint publications

Gilles Freyer

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on : Oct 25, 2011

See more related videos

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on : Oct 25, 2011

See more related videos